Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Genesis Reports Higher Revenues, Flat Net

publication date: Feb 17, 2009
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Genesis Pharmaceuticals Enterprises, Inc. (江波制药) reported that revenues jumped 24% during its Q2 (ended December 31, 2008), but net income moved up only 4%. The company booked $32.9 in revenue for the quarter and recorded a profit of $5.4 million or 11 cents per share. At current levels, Genesis has a market capitalization of less than its cash level.  More details...

Stock Symbol: (OTCBB: GNPH)




Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
ChinaBio® Events
CBPF2016
Suzhou, China
May 18 - 19, 2016
Record attendance of 1008!
See us next year in Shunde!

>> More events...

Other Events
Hong Kong, China
June 15–17, 2016
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors